CRAIG FRANCIS: Open Payments
NPI 1902481286 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 66 payments from 7 companies in 2025. Trend: 2023 $2,342 · 2024 $1,872 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $482 |
| Alkermes, Inc. | 9 | $240 |
| Janssen Pharmaceuticals, Inc | 16 | $221 |
| Neuronetics, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: VRAYLAR, SPRAVATO, VIVITROL, LYBALVI, INVEGA SUSTENNA, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, AUSTEDO XR.
Industry payments across UT — which companies pay providers there.
